€100,000 investment opportunity for central nervous system research

News

Author: Parkinson's Life editorsPublished: 6 June 2018

Prep: Cook: Serves:

Zcube, a research venture of Italian pharmaceutical company Zambon, has invited researchers, scientists and aspiring entrepreneurs to apply for its third international Open Accelerator programme.

The programme – which runs for 12 weeks at the Openzone campus in Milan, Italy – will have a specific focus on the therapeutic areas of the central nervous system and the respiratory system, including rare diseases in these two areas. Upon completing the accelerator, participants will have the chance to win seed investment of up to €100,000 to develop their projects in collaboration with Zambon.

Elena Zambon, president of Zambon, said: “Open Accelerator is a fundamental ‘school’ teaching young researchers how to communicate with the business world and venture capitalists and to take their ideas out of the laboratories and let them become effective opportunities to improve patients’ lives.”

Submissions for the accelerator programme are open until 30 June 2018.

To apply for the Open Accelerator programme click here.

Last Month

Next Month

Go Back

Share this story

Comments

Perspectives

Tony’s two-wheel tour: “One of the best experiences of my life”

Tony reflects on his experience, which might just be the best of his life

Underwater boxing: Parkinson’s patients make a splash

Punching out Parkinson's goes from ring to pool

Parkinson’s in the news: July

This month’s top Parkinson’s disease stories from around the globe

Researchers have finally identified brain cells linked to Parkinson’s disease

For decades, scientists have known that Parkinson’s is associated with the death of dopamine-producing cells in the brain. Now, researchers from the Broad Institute of MIT and Harvard, US, have discovered the specific subtype of brain cells that die in Parkinson’s disease. Using a technique called single-cell RNA signalling, which enables the individual analysis of cells within a tissue for activity and protein production, researchers identified 10 subtypes of dopamine-producing cells within the donated brains of people who died from causes unrelated to Parkinson’s. The team carried out the same investigation on people who had died with Parkinson’s or a condition with similar symptoms called Lewy body dementia. They discovered that only one subtype of the cells had reduced in number – which suggests many of these cells had died while the people were living. It is hoped that the findings could lead to better understanding of Parkinson’s causes and…

Tiny DBS implant shows potential to advance Parkinson’s disease treatment

In an innovative trial by North Bristol NHS Trust, UK, surgeons have succeeded in implanting a tiny deep brain stimulation (DBS) device into a person’s skull. Their aim? To address symptoms of Parkinson’s. Designed with a tiny battery system that is inserted into the skull, the DBS device delivers electric impulses to targeted areas of the brain through electric probes. In doing so, it works to address abnormal brain cell activity associated with Parkinson’s – and may help to ease symptoms. One of around 25 patients selected for the year-long trial has described the device’s impact as “amazing”. Commenting on the results of the trial so far, consultant neurologist Dr Alan Whone of North Bristol NHS Trust said: “We are hopeful that if these findings hold up, we will have a significant technical advance by which to improve Parkinson’s care across the world.”

Could a specialised smartwatch support people with Parkinson’s disease?

A specialised smartwatch, which could help those living with Parkinson’s to better manage their condition, will be rolled out to thousands of people in England. The Parkinson’s Kinetigraph, developed by the National Health Service (NHS) in Plymouth and the University of Plymouth, UK, contains sensors designed to monitor the wearer’s activity and buzz with medication reminders. Data collected from the watch – which detects excessive movement, immobility and sleep disturbances – is shared with healthcare providers, allowing for improvements to physiotherapy and prescriptions based on patient needs. Commenting on the smartwatch’s launch, NHS England chief executive Amanda Pritchard said: “Not only is it better for these people living with Parkinson’s, but it is also more efficient for the NHS, freeing up space and time in hospitals for our hard-working staff.” UK health secretary Sajid Javid, meanwhile, described the Kinetigraph as a “fantastic example of how technology is driving cutting-edge innovation…

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Phone
This field is for validation purposes and should be left unchanged.

€100,000 investment opportunity for central nervous system research

News

Author: Parkinson's Life editorsPublished: 6 June 2018

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Perspectives

Tony’s two-wheel tour: “One of the best experiences of my life”

Health & Fitness

Underwater boxing: Parkinson’s patients make a splash

Global update

Parkinson’s in the news: July

Researchers have finally identified brain cells linked to Parkinson’s disease

Tiny DBS implant shows potential to advance Parkinson’s disease treatment

Could a specialised smartwatch support people with Parkinson’s disease?

{title}

Subscribe

€100,000 investment opportunity for central nervous system research

News

Author: Parkinson's Life editorsPublished: 6 June 2018

Last Month

Next Month

Share this story

Comments

Related articles

Perspectives

Tony’s two-wheel tour: “One of the best experiences of my life”

Health & Fitness

Underwater boxing: Parkinson’s patients make a splash

Global update

Parkinson’s in the news: July

Researchers have finally identified brain cells linked to Parkinson’s disease

Tiny DBS implant shows potential to advance Parkinson’s disease treatment

Could a specialised smartwatch support people with Parkinson’s disease?

{title}

Subscribe

Sign in